For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Hims & Hers Health Inc (NYSE: HIMS) closed at $26.63 up 5.67% from its previous closing price of $25.20. In other words, the price has increased by $5.67 from its previous closing price. On the day, 7.22 million shares were traded. HIMS stock price reached its highest trading level at $26.755 during the session, while it also had its lowest trading level at $25.08.
Ratios:
For a deeper understanding of Hims & Hers Health Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 24.20 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.09. For the most recent quarter (mrq), Quick Ratio is recorded 1.82 and its Current Ratio is at 2.14. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 17, 2024, initiated with a Overweight rating and assigned the stock a target price of $42.
On August 22, 2024, Needham started tracking the stock assigning a Buy rating and target price of $24.Needham initiated its Buy rating on August 22, 2024, with a $24 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 02 ’25 when Chi Michael bought 2,055 shares for $24.62 per share.
Okupe Oluyemi sold 4,213 shares of HIMS for $126,318 on Dec 26 ’24. The Chief Financial Officer now owns 128,365 shares after completing the transaction at $29.98 per share. On Dec 24 ’24, another insider, Chi Michael, who serves as the Chief Commercial Officer of the company, sold 17,303 shares for $27.97 each. As a result, the insider received 483,965 and left with 193,601 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 5818095616 and an Enterprise Value of 5575385600. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 61.60, and their Forward P/E ratio for the next fiscal year is 30.00. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.95 while its Price-to-Book (P/B) ratio in mrq is 13.18. Its current Enterprise Value per Revenue stands at 4.489 whereas that against EBITDA is 93.356.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $35.02, while it has fallen to a 52-week low of $8.09. The 50-Day Moving Average of the stock is 1.27%, while the 200-Day Moving Average is calculated to be 35.03%.
Shares Statistics:
For the past three months, HIMS has traded an average of 17.13M shares per day and 11796120 over the past ten days. A total of 209.44M shares are outstanding, with a floating share count of 177.44M. Insiders hold about 18.77% of the company’s shares, while institutions hold 56.02% stake in the company. Shares short for HIMS as of 1734048000 were 42972111 with a Short Ratio of 2.51, compared to 1731628800 on 39517672. Therefore, it implies a Short% of Shares Outstanding of 42972111 and a Short% of Float of 22.41.
